Press Release: Global Wellness Signs Definitive Agreement with Cannvalate Australia
Cannabis Law Report
AUGUST 10, 2021
This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. from 2020 to 2030 and generate revenue of $151.7 billion in 2030. 2 Pain 1994 Apr;57(1):5-15. 3 Psychol Res Behav Manag.
105 
Let's personalize your content